Clinical Trial Update: Continuous Intrathecal Baclofen Infusion for Chronic Spasticity [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating continuous intrathecal baclofen infusion for chronic spasticity was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity

Drugs mentioned

• LIORESAL (BACLOFEN)

Snippet

Sponsor: Flowonix Medical | Conditions: Spasticity | Phase 3 | Status: WITHDRAWN